Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 7Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 4Myelodysplastic Syndromes 4Lymphoma 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Lymphoid 3Leukemia, B-Cell 3Leukemia 3Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Melanoma 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Diseases 2Bone Marrow Diseases 2Sarcoma, Myeloid 1Sarcoma 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Neuroblastoma 1

Interventions

Cyclophosphamide 10Magnetic Resonance Spectroscopy 8Temozolomide 6Biopsy 6dinutuximab 5X-Rays 5Topotecan 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Irinotecan 5Etoposide 3Colony-Stimulating Factors 3ulixertinib 2tipifarnib 2selpercatinib 2sargramostim 2pembrolizumab 2palbociclib 2naxitamab 2larotrectinib 2ivosidenib 2fludarabine phosphate 2fludarabine 2etoposide phosphate 2erdafitinib 2ensartinib 2Lenalidomide 2Isotretinoin 2Granulocyte-Macrophage Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neuroblastoma × Mesna × Clear all
NCT04947501 2025-08-05

A Study of N9 Chemotherapy in Children With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
26 enrolled
CNS

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡